key: cord-0785379-1wxlrr5x authors: Baiocchi, Glauco; Aguiar, Samuel; Duprat, Joao P.; Coimbra, Felipe J. F.; Makdissi, Fabiana B.; Vartanian, José G.; Zequi, Stenio de C.; Gross, Jefferson L.; Nakagawa, Suely A.; Yazbek, Guilherme; Diniz, Thiago P.; Gonçalves, Bruna T.; Zurstrassen, Charles E.; Campos, Heloisa G. do A.; Joaquim, Eduardo H. G.; França e Silva, Ivan A.; Kowalski, Luiz P. title: Early postoperative outcomes among patients with delayed surgeries after preoperative positive test for SARS‐CoV‐2: A case‐control study from a single institution date: 2021-01-11 journal: J Surg Oncol DOI: 10.1002/jso.26377 sha: 47572ea01d587f82da7c840c61e9b6fb6c864198 doc_id: 785379 cord_uid: 1wxlrr5x BACKGROUND: There are limited data on surgical complications for patients that have delayed surgery after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. We aimed to analyze the surgical outcomes of patients submitted to surgery after recovery from SARS‐CoV‐2 infection. METHODS: Asymptomatic patients that had surgery delayed after preoperative reverse‐transcription polymerase chain reaction (RT‐PCR) for SARS‐CoV‐2 were matched in a 1:2 ratio for age, type of surgery and American Society of Anesthesiologists to patients with negative RT‐PCR for SARS‐CoV‐2. RESULTS: About 1253 patients underwent surgical procedures and were subjected to screening for SARS‐CoV‐2. Forty‐nine cases with a delayed surgery were included in the coronavirus disease (COVID) recovery (COVID‐rec) group and were matched to 98 patients included in the COVID negative (COVID‐neg) group. Overall, 22 (15%) patients had 30‐days postoperative complications, but there was no statistically difference between groups –16.3% for COVID‐rec and 14.3% for COVID‐neg, respectively (odds ratio [OR] 1.17:95% confidence interval [CI] 0.45–3.0; p = .74). Moreover, we did not find difference regarding grades more than or equal to 3 complication rates – 8.2% for COVID‐rec and 6.1% for COVID‐neg (OR 1.36:95%CI 0.36‐5.0; p = .64). There were no pulmonary complications or SARS‐CoV‐2 related infection and no deaths within the 30‐days after surgery. CONCLUSIONS: Our study suggests that patients with delayed elective surgeries due to asymptomatic preoperative positive SARS‐CoV‐2 test are not at higher risk of postoperative complications. The new coronavirus (SARS-CoV-2) pandemic has been impairing the diagnosis and treatment of chronic diseases with major impact on public health, such as cardiovascular disease and cancer. This could be justified by the concern among oncological patients after several reports pointed to the worst outcomes for SARS-CoV-2 disease during cancer treatment. 1 In this setting, actions for protecting the access to health services have been proposed and are under practice during the pandemic. Despite the weakness of evidence, preoperative screening for SARS-CoV-19 has been proposed for elective cancer surgeries in Europe 6 and North America, 7 and also became a recommendation in Brazil since April 2020. 8 Therefore, we have implemented universal screening for SARS-CoV-2 with reverse-transcription polymerase chain reaction (RT-PCR) nasopharyngeal swabs for all surgical procedures in our institution since late April 2020. Notably, we found a preoperative positivity rate of 7.6% among asymptomatic patients scheduled for elective surgeries. 9 These patients had their surgeries postponed, and the next raised question is about the safer strategy for re-scheduling. Although it has been suggested a significant increase in morbidity and mortality rates for perioperative SARS-CoV-2 positive patients, it is not clear if these patients still have an increased risk of surgical complications in a delayed surgery after complete recovery from SARS-CoV-2 infection. Our aim was to evaluate the surgical morbidity and mortality among patients with delayed surgery due to asymptomatic positive SARS-CoV-2 at a tertiary comprehensive cancer center. Since April 22, 2020, all patients scheduled for surgical procedures at AC Camargo Cancer Center were subjected to preoperative RT-PCR test for SARS-CoV-2. The preoperative screening protocol included: (1) All patients with scheduled elective surgery were contacted for performing SARS-CoV-2 test, 2-3 days before surgical admission; (2) patients underwent epidemiological survey about flu symptoms or contact with infected relatives 5 days before surgery; (3) patients were tested with RT-PCR for SARS-CoV-2 from nasopharyngeal swabs; (4) before and after surgery, all patients were oriented to remain in social isolation; and (5) patients with positive results had the admission canceled, a new SARS-CoV-2 test was collected after 14 days, and the surgery was re-scheduled only after a negative test. There were no additional costs for the patients with respect to screening and the study had the Institutional Review Board approval (#4.072.209). From April 22 to July 2, 2020, a total of 1253 patients underwent surgical procedures at AC Camargo Cancer Center and were subjected to screening for SARS-CoV-2 by nasopharyngeal swabs. Eighty-five (6.8%) tests were positive for SARS-CoV-2% and 17.6% (15/85) positive cases had emergency procedures. All elective surgeries with positive SARS-CoV-2 had admission canceled and surgery postponed (n = 70). Until the end of July 2, 49 cases have already been operated after a subsequent negative test and were included in the COVID recovery (COVID-rec) group. Figure 1 The patients in the COVID-rec group (n = 49) were matched in a 1:2 ratio for age, type of surgery (oncological surgeries or nononcological surgeries) and ASA (1 and 2 vs. 3 and 4) to those in the COVID-neg group (n = 98). We calculated the propensity score using a logistic regression model including type of surgery, ASA and age to balance these variables between the studied groups. A database was constructed using SPSS, version 20.0 for Mac (SPSS; Inc.). Descriptive statistics were described for both groups. The χ 2 , Fisher's exact test were used to analyze the correlations between categorical variables and Mann-Whitney for continuous variables. Odds ratios (ORs) were assessed with logistic regression. For all tests, p < .05 was considered to be significant. Forty-nine cases had elective surgery delayed due to asymptomatic positive RT-PCR for SARS-CoV-2 (COVID-rec) and 98 controls with preoperative negative RT-PCR for SARS-CoV-2 (COVID-neg) were included in the study. The median time between the positive SARS-CoV-2 and definitive surgery was 25 days (range, 12-84). Interestingly, 3 (6.1%) cases had the second positive test, and only had a negative test after 20, 35, and 82 days. Data on symptoms after positive RT-PCR for SARS-CoV-2 were retrieved from 48 (98%) cases, and notably only 9 (22.9%) cases had symptoms related to SARS-CoV-2 infection. All cases that developed symptoms had a mild presentation such as coryza, myalgia and anosmia, and any patient required hospital admission. Of the three cases with a second positive test, two developed symptoms but any of them had surgical complications. There were no statistically differences between groups regarding age, body mass index, gender, performance status, surgical time length, and hospital stay length. For the COVID-rec group, 25 (51%) cases had oncological surgeries and 24 (49%) nononcological surgeries. In addition, 2 (4.1%) cases of COVID-rec groups had emergency surgeries due to complications during the delaying period. For COVID-neg group, 6 (6.1%) cases with emergency surgeries were included (p = .71). Table 1 According to the World Health Organization, Brazil is the second country in the number of cases and deaths by COVID-19 disease. 13 After considering the implications in delaying oncologic care, and the availability of ward and ICU beds, our institution opted to resume elective surgeries and implemented the strategy of universal preoperative testing. In our preliminary experience including 540 patients, the positivity rate was 7.6% among asymptomatic preoperative patients, allowing us to perform 84.1% of the surgeries electively scheduled. 9 Recently, the published data from the COVIDSurg collaborative 4 included 1115 patients with perioperative positive SARS-CoV-2 (835 with emergency surgeries and 280 with elective surgeries). If ward and ICU beds are available, elective surgeries can be scheduled safely with preoperative screening for SARS-CoV-2 based on systematic RT-PCR SARS-CoV-2 testing Do patients with cancer have a poorer prognosis of COVID-19? An experience in Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China COVID-19 and cancer Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study Factors associated with surgical mortality and complications among patients with and without coronavirus disease 2019 (COVID-19) in Italy Surgical oncology at the time of COVID-19 outbreak COVID-19 Preoperative assessment and testing: from surge to recovery Surgical cancer care in the COVID-19 era: front line views and consensus Value of preoperative testing for SARS-CoV-2 for elective surgeries in a cancer center during the peak of pandemic in Brazil A review of ASA physical status -historical perspectives and modern developments Toxicity and response criteria of the Eastern Cooperative Oncology Group Classification of surgical complications COVID-19) Dashboard. Situation by country, territory or area Delaying surgery for patients with a previous SARS CoV-2 infection Early postoperative outcomes among patients with delayed surgeries after preoperative positive test for SARS-CoV-2: A case-control study from a single institution The study did not receive funding. The authors declare that there are no conflict of interests. The data that support the findings of this study are available from the corresponding author upon reasonable request.